Logo

HPV

AACC Issues New Cervical Cancer Detection Guidance

The new guidance includes an ideal lab report template and synthesizes guidelines previously issued by three other organizations.

Becton Dickinson Onclarity HPV Assay FDA-Cleared for Use With Hologic ThinPrep Pap Test

The firm said the ThinPrep is among the most common Pap test collection vials in the US and the new approval will expand access to the Onclarity HPV assay.

Fujirebio Europe to Distribute Self-Screen Cervical Cancer Test

The test is designed to detect elevated methylation levels of cervical cancer biomarkers and may be used as a triage follow-up test of HPV-positive women.

Naveris Nabs $33.4M Series A Round Expansion to Further Commercialize Virus-Related Cancer Tests

The new funding brings the total investment in the firm to $51 million, which Naveris will use for commercialization of its NavDx assay.

Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval

The GynTect assay detects oncogenic DNA methylation markers from cervical smear samples following abnormal cancer-screen findings.

Jul 6, 2022

Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition

Apr 19, 2022

New York State Approves Enzo Biochem HPV Molecular Test

Feb 11, 2022

Yemaachi Launches HPV Molecular Test in Ghana for At-Home Cervical Cancer Risk Assessment
Premium

Oct 28, 2021

Becton Dickinson Expanding High-Throughput BD Cor Menu After US Launch
Premium

Oct 12, 2021

Genematrix HPV Detection Test Nabs CE Mark

Oct 6, 2021

Princess Margaret Researchers Improve HPV Detection in Blood With NGS Method
Premium

Aug 25, 2021

FDA Approves BD High-Throughput Cor System, HPV Screening Assay

May 13, 2021

Becton Dickinson Gets CE Mark for At-Home Self-Collected HPV Test Indication

Feb 24, 2021

Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

Feb 12, 2021

Naveris Explores New Applications for ctDNA HPV Head and Neck Cancer Test
Premium

Dec 15, 2020

Naveris Closes $17M Series A Round to Advance Virus-Related Cancer MDx Tests

Nov 18, 2020

Qiagen to Develop Companion Diagnostic for BioNTech Head, Neck Cancer Treatment

Oct 22, 2020

Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19
Premium

Sep 23, 2020

Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

Sep 20, 2020

HPV, p16 May Offer Different Prognostic Clues in Oropharyngeal Cancer, ESMO Data Reveals
Premium

Aug 3, 2020

Cervical Cancer Study in Ugandan Women Finds HPV-Specific Tumor DNA Methylation, Gene Expression

Jul 22, 2020

BD Receives FDA Supplemental Premarket Approval for Extended Genotyping HPV MDx

Jul 20, 2020

NeuMoDx Molecular Receives CE Mark for HPV Diagnostic Test

Apr 22, 2020

Roche Diagnostics Q1 Sales Essentially Flat

Apr 21, 2020

Roche Gets FDA Approval for HPV Test Used With Cobas 6800/8800 Platforms

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.